The Relations Between False Positive and Negative Screens and Smoking Cessation and Relapse in the National Lung Screening Trial : Implications for Public Health
© The Author 2015. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..
INTRODUCTION: Lung screening is an opportunity for smoking cessation and relapse prevention, but smoking behaviors may differ across screening results. Changes in smoking were evaluated among 18 840 current and former smokers aged 55-74 scheduled to receive three annual lung screenings.
METHODS: Participants were randomized to low-dose computed tomography or single-view chest radiography in the American College of Radiology/National Lung Screening Trial. Outcome measures included point and sustained (6-month) abstinence and motivation to quit among smokers; and relapse among smokers who quit during follow-up, recent quitters (quit < 6 months), and long-term former smokers (quit ≥ 6 months).
RESULTS: During five years of follow-up, annual point prevalence quit rates ranged from 11.6%-13.4%; 48% of current smokers reported a quit attempt and 7% of long-term former smokers relapsed. Any false positive screening result was associated with subsequent increased point (multivariable hazard ratio HR = 1.23, 95% CI = 1.13, 1.35) and sustained (HR = 1.28, 95% CI = 1.15, 1.43) abstinence among smokers. Recent quitters with ≥1 false positive screen were less likely to relapse (HR = 0.72, 95% CI = 0.54, 0.96). Screening result was not associated with relapse among long-term former smokers or among baseline smokers who quit during follow-up.
CONCLUSIONS: A false positive screen was associated with increased smoking cessation and less relapse among recent quitters. Consistently negative screens were not associated with greater relapse among long-term former smokers. Given the Affordable Care Act requires most health plans to cover smoking cessation and lung screening, the impact and cost-effectiveness of lung screening could be further enhanced with the addition of smoking cessation interventions.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco - 18(2016), 1 vom: 10. Jan., Seite 17-24 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Clark, Melissa A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Completed 21.07.2016 Date Revised 08.04.2022 published: Print-Electronic ClinicalTrials.gov: NCT00047385 Citation Status MEDLINE |
|---|
| doi: |
10.1093/ntr/ntv037 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM246848758 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM246848758 | ||
| 003 | DE-627 | ||
| 005 | 20231224143940.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/ntr/ntv037 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0822.xml |
| 035 | |a (DE-627)NLM246848758 | ||
| 035 | |a (NLM)25746779 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Clark, Melissa A |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Relations Between False Positive and Negative Screens and Smoking Cessation and Relapse in the National Lung Screening Trial |b Implications for Public Health |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.07.2016 | ||
| 500 | |a Date Revised 08.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ClinicalTrials.gov: NCT00047385 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author 2015. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com. | ||
| 520 | |a INTRODUCTION: Lung screening is an opportunity for smoking cessation and relapse prevention, but smoking behaviors may differ across screening results. Changes in smoking were evaluated among 18 840 current and former smokers aged 55-74 scheduled to receive three annual lung screenings | ||
| 520 | |a METHODS: Participants were randomized to low-dose computed tomography or single-view chest radiography in the American College of Radiology/National Lung Screening Trial. Outcome measures included point and sustained (6-month) abstinence and motivation to quit among smokers; and relapse among smokers who quit during follow-up, recent quitters (quit < 6 months), and long-term former smokers (quit ≥ 6 months) | ||
| 520 | |a RESULTS: During five years of follow-up, annual point prevalence quit rates ranged from 11.6%-13.4%; 48% of current smokers reported a quit attempt and 7% of long-term former smokers relapsed. Any false positive screening result was associated with subsequent increased point (multivariable hazard ratio HR = 1.23, 95% CI = 1.13, 1.35) and sustained (HR = 1.28, 95% CI = 1.15, 1.43) abstinence among smokers. Recent quitters with ≥1 false positive screen were less likely to relapse (HR = 0.72, 95% CI = 0.54, 0.96). Screening result was not associated with relapse among long-term former smokers or among baseline smokers who quit during follow-up | ||
| 520 | |a CONCLUSIONS: A false positive screen was associated with increased smoking cessation and less relapse among recent quitters. Consistently negative screens were not associated with greater relapse among long-term former smokers. Given the Affordable Care Act requires most health plans to cover smoking cessation and lung screening, the impact and cost-effectiveness of lung screening could be further enhanced with the addition of smoking cessation interventions | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 700 | 1 | |a Gorelick, Jeremy J |e verfasserin |4 aut | |
| 700 | 1 | |a Sicks, JoRean D |e verfasserin |4 aut | |
| 700 | 1 | |a Park, Elyse R |e verfasserin |4 aut | |
| 700 | 1 | |a Graham, Amanda L |e verfasserin |4 aut | |
| 700 | 1 | |a Abrams, David B |e verfasserin |4 aut | |
| 700 | 1 | |a Gareen, Ilana F |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco |d 1997 |g 18(2016), 1 vom: 10. Jan., Seite 17-24 |w (DE-627)NLM097536172 |x 1469-994X |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2016 |g number:1 |g day:10 |g month:01 |g pages:17-24 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/ntr/ntv037 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2016 |e 1 |b 10 |c 01 |h 17-24 | ||